A clinical trial to study the effect of the drug SANGU CHUNNAM in patients having Azhal thalai Nokkadu (Sinusitis)

An open Non-Randomized clinical trial of Sangu Chunnam in Azhal Thalai Nokkadu (SINUSITIS)

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/03/012379

Enrollment

Registered

2018-03-06

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- AZHAL THALAI NOOKADU (SINUSITIS)

Interventions

Intervention1: SANGU CHUNNAM: 130 mg of Sangu chunnam is administrated twice a day with honey for 48 days Control Intervention1: NIL: NIL

Eligibility

Inclusion criteria

Inclusion criteria: Age between 16 to 60 years Both male and female Nasal congestion Running Nose Headache Heaviness of Head Pain and Tenderness over at PNS area Recurrent Sneezing Patients with positive x-ray findings

Exclusion criteria

Exclusion criteria: Age factor - below 16 and above 60 years Pregnancy Lactation Diabetes Mellitus Vasomotor Rhinitis Migraine Otitis Media Malignancy of PNS

Design outcomes

Primary

Measure	Time frame
Outcome is estimated by scoring the clinical symptoms and investigations before and after treatmentTimepoint: 48 days	—

Secondary

Measure	Time frame
NILTimepoint: NIL	—

Countries

India

Contacts

Public ContactDr Indumathy V

Government Siddha Medical College

nanbu.sumi@gmail.com9443279412

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026